Skip to content

The predictive value of Residual Cholesterol on Post-Stroke Cognitive Impairment

The predictive value of Residual Cholesterol on Post-Stroke Cognitive Impairment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077166
Enrollment
Unknown
Registered
2023-11-01
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post stroke cognitive impairment

Interventions

Post stroke cognitive impairment:Not involved

Sponsors

Beijing Pinggu District Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old, regardless of gender; 2. Patients who meet the diagnostic criteria for AIS and are the first to experience AIS; 3. Patients who voluntarily participate and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with previous cognitive impairment; 2. Patients who have used cognitive impairment drugs (such as antipsychotic drug chlorpromazine, central anesthetic ketamine, benzodiazepine drug diazepam, cholinergic receptor antagonist anisodamine, etc.) within the first two weeks; 3. Patients who are unable to complete cognitive assessment of neurological function.

Design outcomes

Primary

MeasureTime frame
montreal cognitive assessment;Residual cholesterol;

Secondary

MeasureTime frame
blood specimen;Blood pressure at admission, stroke onset to visit time, stroke subtypes (TOAST classification, OCSP classification), stroke severity (NHISS score), infarct size, location and number of brain tissue lesions, and white matter lesion grading (Fazekas scale);

Countries

China

Contacts

Public ContactXiaofen Jiang

Beijing Pinggu District Hospital

653422751@qq.com+86 158 0348 5082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026